Displaying drugs 14476 - 14500 of 14561 in total
GI-181771X
Gski181771 X is under investigation in clinical trial NCT00600743 (Effect of a CCK-1R Agonist on Food Intake in Humans).
Investigational
Debromohymenialdisine
Experimental
Nifurpirinol
Experimental
Vet approved
Ondelopran
Ondelopran has been used in trials studying the treatment of Alcohol Dependence.
Investigational
Ivarmacitinib
Ivarmacitinib (SHR0302) is a selective inhibitor of Janus kinase 1 (JAK1) under investigation for the treatment of various immuno-inflammatory conditions. While ivarmactinib has yet to receive marketing authorization, as of February 2022 clinical trials are ongoing or completed evaluating its use in atopic dermatitis,[L40604,L40619,L40629] ankylosing spondylitis, rheumatoid arthritis, psoriatic arthritis,...
Experimental
Investigational
Matched Description: … graft-versus-host disease,[A245653,L40599] vitiligo,[L40609] ulcerative colitis,[L40614] alopecia areata,[L40624] and …
Acylated ceftazidime
Experimental
Bilh 434
Experimental
PLX-4720
Experimental
L-778123
Experimental
(S,R)-fidarestat
Experimental
Ceftazidime BATSI
Experimental
Displaying drugs 14476 - 14500 of 14561 in total